{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Araos R"],"funding":["National Institute of Allergy and Infectious Diseases","Diane Belfer Program for Human Microbial Ecology (M. J. B.)","Becas Chile, Comision Nacional de Investigacion Cientifica y Tecnologica","NIDDK NIH HHS","NIAID NIH HHS","National Institutes of Health",", Gobierno de Chile"],"pagination":["937-943"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5019285"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["63(7)"],"pubmed_abstract":["Background
The emergence and dissemination of multidrug-resistant organisms (MDROs) is a global threat. Characterizing the human microbiome among hospitalized patients and identifying unique microbial signatures among those patients who acquire MDROs may identify novel infection prevention strategies.Methods
Adult patients admitted to 5 general medical-surgical floors at a 649-bed, tertiary care center in Boston, Massachusetts, were classified according to in-hospital antimicrobial exposure and MDRO colonization status. Within 48 hours of hospital admission (baseline) and at discharge (follow-up), rectal swab samples were obtained, and compared with samples from an external control group of healthy persons from the community. DNA was extracted from samples, next-generation "],"journal":["Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"],"pubmed_title":["Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms."],"pmcid":["PMC5019285"],"funding_grant_id":["K24 AI119158","R01 DK090989"],"pubmed_authors":["Tai AK","Blaser MJ","Snyder GM","Araos R","D'Agata EMC"],"additional_accession":[]},"is_claimable":false,"name":"Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.","description":"Background
The emergence and dissemination of multidrug-resistant organisms (MDROs) is a global threat. Characterizing the human microbiome among hospitalized patients and identifying unique microbial signatures among those patients who acquire MDROs may identify novel infection prevention strategies.Methods
Adult patients admitted to 5 general medical-surgical floors at a 649-bed, tertiary care center in Boston, Massachusetts, were classified according to in-hospital antimicrobial exposure and MDRO colonization status. Within 48 hours of hospital admission (baseline) and at discharge (follow-up), rectal swab samples were obtained, and compared with samples from an external control group of healthy persons from the community. DNA was extracted from samples, next-generation ","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Oct","modification":"2026-07-15T23:57:44.241Z","creation":"2019-03-27T02:23:58Z"},"accession":"S-EPMC5019285","cross_references":{"pubmed":["27358350"],"doi":["10.1093/cid/ciw426"]}}